Health and Medicine

FSI’s researchers assess health and medicine through the lenses of economics, nutrition and politics. They’re studying and influencing public health policies of local and national governments and the roles that corporations and nongovernmental organizations play in providing health care around the world. Scholars look at how governance affects citizens’ health, how children’s health care access affects the aging process and how to improve children’s health in Guatemala and rural China. They want to know what it will take for people to cook more safely and breathe more easily in developing countries.

FSI professors investigate how lifestyles affect health. What good does gardening do for older Americans? What are the benefits of eating organic food or growing genetically modified rice in China? They study cost-effectiveness by examining programs like those aimed at preventing the spread of tuberculosis in Russian prisons. Policies that impact obesity and undernutrition are examined; as are the public health implications of limiting salt in processed foods and the role of smoking among men who work in Chinese factories. FSI health research looks at sweeping domestic policies like the Affordable Care Act and the role of foreign aid in affecting the price of HIV drugs in Africa.

0
Master's Student Alumni, Health Policy
preeti_panda.jpg MD

Preeti is pursuing the Master’s of Science in Health Policy. She is currently a pediatric emergency medicine fellow at Stanford University School of Medicine. Her research focuses on the intersection of human trafficking and health care. She is particularly interested in trauma prevention and resource provision for trafficked and at-risk youth presenting to acute care settings. She completed her undergraduate degree in Biology and Global Health from Cornell University, and earned an M.D. with Distinction in Advocacy from Albany Medical College. Preeti completed her pediatric residency training at Rainbow Babies and Children’s Hospital/Case Western Reserve University. As a current Stanford Maternal & Child Health Research Institute (MCHRI) Fellow, her research and master’s degree are fully funded by grants from the MCHRI.

CV
0
Master's Student Alumni, Health Policy
erin_holsinger_headshot-2023.jpg MD

Erin Holsinger is a Master’s student at the Center for Health Policy and a Fellow in Academic General Medicine. She started working at CHP in 2018 when she joined the LongSHOT team, working on data analysis for the team’s research into the impact that gun ownership has on mortality in California residents. During the early days of the pandemic, she also contributed to work with CHP’s SC-COSMO team, where she provided data about public health orders at each of California’s 58 counties. Erin received her BA at the University of Texas, her MD at Baylor College of Medicine and worked as a Pediatrician for 15 years prior to moving to California.

0
PhD Student, Health Policy
harry_koos_headshot-stanofrd.jpg

Harry is a PhD student in Health Policy (Health Economics) at the Stanford School of Medicine. His research interests include pricing and market competition among hospitals, innovation and adoption of medical technologies, and wasted spending in the U.S. healthcare system. Harry earned a BS in Industrial Engineering from Cal Poly, San Luis Obispo and an MS in Management Science & Engineering from Stanford University. During his master’s, he conducted research with the Clinical Excellence Research Center (CERC), Systems Utilization Research for Stanford Medicine (SURF), and Health Equity Advancement through Research and Technology (Heart Lab). He was also a Summer Fellow for the Market Oversight & Transparency team at the Massachusetts Health Policy Commission. During his undergrad, he gained experience in the medical device, hospital, and biotech industries through internships with Medtronic, Stanford Health Care, and Cepheid.

0
PhD Student, Health Policy
nova_bradford_head-2023.jpg

Nova Bradford is a PhD candidate studying management and organizations at Stanford’s Department of Health Policy, where she is a Knight-Hennessey Scholar (Stanford’s equivalent of Rhodes). She studies how leaders and organizations respond to environments that are constrained, uncertain, or in flux. Her dissertation—advised by Sara Singer, Hayagreeva Rao, and Melissa Valentine—examines innovation, strategic decision-making, and artificial intelligence using ethnographic and computational methods. Bradford received the “Outstanding Paper Based on a Dissertation” award from the Academy of Management’s Health Care Management division. During her PhD, she taught courses in the Graduate School of Business and Department of Health Policy. Outside of her PhD, she is a stand-up comedian, playwright, and theater director, with work that has been featured in Rolling Stone, The New York Times, The Washington Post, and more.


 

CV
Date Label
0
Master's Student Alumni, Health Policy
Jillian Caldwell-cropped.jpg

Jillian is a nephrologist and aspiring health services researcher. She received her B.S. in neuroscience from McGill University, D.O. from Chicago College of Osteopathic Medicine and completed internal medicine residency training at University of Illinois Chicago before returning home to the Bay Area to complete nephrology fellowship at Stanford. As a first-year fellow, she was awarded the American Kidney Fund Clinical Scientist in Nephrology grant to study immunologic matching between kidney donors and recipients and its effect on equitable access to transplantation. She hopes her work will inform policy decisions regarding kidney allocation so as to improve access to kidney transplant and transplant outcomes for minority communities and disadvantaged groups.

0
PhD Student, Health Policy
eliza_ennis_head-2023.jpg

Eliza Ennis is a Health Policy PhD student in the Decision Sciences track, a Knight-Hennessy Scholar, and NSF Graduate Research Fellow. She uses simulation modeling, causal inference, and mixed social science research methods to answer questions about the effectiveness of health policies and programs. Her work spans substance use, infectious disease, and reproductive, maternal, and infant health. She has been awarded two Lee B. Lusted awards in Applied Health Economics and Health Services, Outcomes, and Policy Research by the Society for Medical Decision Making. Previously, she worked on global health strategy at Dalberg Global Development Advisors. There, she designed structures for health financing reform, supported U.S. policy response to the Covid-19 pandemic, and developed a quantitative model to evaluate iron deficiency reduction approaches in sub-Saharan Africa and South Asia. She graduated from Harvard University with a bachelor’s degree in social studies with a focus on international relations and the Modern Middle East and a secondary in Global health and health policy. She was awarded the Stanley H. Hoffman Undergraduate Research Fellowship and also established and led the Women’s Media Center research team in Washington, D.C. She aims to drive equitable health outcomes by scaling effective health system design.

CV
Date Label
0
Master's Student Alumni, Health Policy
james_dickerson.jpg MD

James C. Dickerson, MD is a current oncology fellow at Stanford University, as well as a AHRQ health services research fellow. He is interested in understanding the extent of health disparities in cancer care, both in the United States and in low income countries. His prior research has focused on these domains, working on projects in Belize, Nigeria, and California. He received his B.A. from Vanderbilt University, and then returned home to receive his M.D. from the University of Mississippi. He completed his internal medicine residency at Stanford in 2021 and stayed at Stanford for his hematology/oncology fellowship.

0
Master's Student, Health Policy Alumni
suen_wesley_headshot93_copy.jpg

Yat Chun (Wesley) Suen is a Health Policy MS student. His research interests are centered around advancing the translation of healthcare innovations through implementing and improving government programs and regulatory policies. Prior to Stanford, Wesley graduated summa cum laude from the University of Chicago, with a degree in Economics.

Date Label
0
Master's Student Alumni, Health Policy
clifford_sheckter.jpg MD

Dr. Sheckter is a burn surgeon/intensivist at Stanford Hospital and Santa Clara Valley Medical Center. He graduated from UCLA with a BS in Anthropology and earned summa cum laude and Phi Beta Kappa honors. He attended USC for medical school on an academic scholarship and graduated valedictorian with Alpha Omega Alpha honors. He completed his Plastic Surgery training at Stanford in 2020 and a fellowship in Surgical Critical Care at the University of Washington in 2021. His current research investigates the relationship between healthcare financial structures and the value of healthcare delivery in surgery.

-

Image
Luca Maini
Luca Maini, PhD, Department of Health Care Policy, Harvard Medical School. He focuses on the intersection between industrial organization and health economics and the regulation of pharmaceutical markets.

Talk Title — Mergers that Matter: The Impact of M&A Activity in Pharmaceutical Markets

 

We study how selection affects the analysis of consolidation through merger retrospectives. Using a novel dataset of pharmaceutical acquisitions from 2007–2019, we characterize M&A activity in the pharmaceutical market and examine its impact on prices and coverage of on-patent branded drugs. Approximately one-third of branded drugs are acquired by a different company during their patent terms. Most acquisitions involve drugs that are not direct competitors: only a minority of “overlap” acquisitions consolidate drug ownership in the same therapeutic area. Following an acquisition, acquired products experience an 8% price increase on average and are 1% more likely to be on a restricted formulary coverage tier. However, the effects are concentrated within two relatively small groups of deals less likely to raise regulatory scrutiny. The first group comprises within-market acquisitions whose value falls below the threshold for mandatory reporting. The second group comprises cross-market deals between small pharmaceutical companies, which are unlikely to be considered problematic even when disclosed. Following these acquisitions, prices increase by 60% on average, and drugs are 8% more likely to be on a restricted formulary coverage tier. Our results suggest that antitrust authorities are usually effective at preventing acquisitions that would hurt consumer welfare and that merger retrospectives that do not adequately account for regulatory oversight will underestimate the impact of M&A activity.

Encina Commons, Room 119

Seminars
Subscribe to Health and Medicine